MPEP § 2413 — Content of a “Sequence Listing XML” and Form and Format of the “Sequence Listing XML” File
Ninth Edition, Revision 01.2024 · last revised R-01.2024
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
In order to ensure consistency and uniformity of a “Sequence Listing XML,” 37 CFR 1.833 defines the content of the “Sequence Listing XML.” 37 CFR 1.834 details the specifics on the technical form and format of the .xml file containing the “Sequence Listing XML” XML file.
Contents
- 2413.01 Parts of the “Sequence Listing XML”
- 2413.01(a) The “Sequence Listing XML” is a Single File Encoded Using Unicode UTF-8
- 2413.01(b) The “Sequence Listing XML” Must Be Valid According To the DTD
- 2413.01(c) The “Sequence Listing XML” Must Contain an XML Declaration
- 2413.01(d) The “Sequence Listing XML” Must Contain a DOCTYPE Declaration
- 2413.01(e) The “Sequence Listing XML” Must Contain a Root Element
- 2413.01(f) The “Sequence Listing XML” Must Contain a General Information Part
- 2413.01(g) The “Sequence Listing XML” Must Contain a Sequence Data Part
- 2413.01(h) Language Dependent Free Text Qualifier Values in the English Language
- 2413.01(i) Title Element in “Sequence Listing XML”
- 2413.02 Form and Format of the XML file containing the “Sequence Listing XML”
- 2413.03 How to Submit the “Sequence Listing XML”
- 2413.04 Requirements Regarding Incorporation By Reference of the “Sequence Listing XML”
- 2413.05 Presumptions Regarding Compliance
Cited authority
- 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- 37 CFR 1.833 Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022
- 37 CFR 1.834 Form and format for nucleotide and/ or amino acid sequence submissions as the ‘‘Sequence Listing XML’’ in patent applications filed on or after July 1, 2022